Senior insider sale
MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$11.68M
26.57K shares
What this filing means
BATE KENNETH plans to sell 26.57K shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $11.68M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/5/2025ACC: 0001950047-25-008473
Director
Since Jun 2019
26.57K
Shares to sell
$11.68M
Approx. market value
16.57K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of options under a registered plan
Cash
11/5/2025
16.57KTotal acquired16.57K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/5/2025 | Exercise of options under a registered plan Cash | 16.57K | — |
| Total | 16.57K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10K
Market value
$3.65M
8/15/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
16.57K
Market value
$8.03M
11/5/2025
Total
Units
26.57K
Value
$11.68M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/15/2025 | 10K | $3.65M | — | Completed |
| Planned — Approximate Date | ||||
11/5/2025 | 16.57K | $8.03M | NASDAQ | Planned |
| Total | 26.57K | $11.68M | ||